While lower than injectable averages, it is still clinically meaningful
Less frequent AEs like hypoglycemia, is mostly seen in combination with insulin or sulfonylureas (157) and some reports of pancreatobiliary complications are partially explained by direct altered absorption of bile acids, rapid weight loss or changes in the gallbladder motility with increased risk of pancreatitis, even though it is extremely rare (160)
In terms of weight loss results, the Wegovy pill demonstrated an average weight loss of approximately 13.6% over 64 weeks in its Phase 3 trial, whilst Foundayo showed an average weight loss of approximately 11% over 72 weeks at the highest dose
With the recent announcement that the shortage of Ozempic and Wegovy is officially over, the FDA has declared that compounding pharmacies must stop producing and selling compounded semaglutide by May 22, 2025
2-day UPS shipping with thoughtful packaging (cotton-ball vial stabilization flags real pharmacy hygiene)
Second, drop back to the previous dose for 1 to 2 weeks, then re-attempt the increase